Our state-of-the-art cGMP, US FDA-registered, and FSSC 22000-certified manufacturing complex delivers batch-to-batch consistent, standardized raw materials and finished phytopharmaceutical formulations tailored to European Pharmacopoeia (Ph. Eur.) and Polish GIS safety standards.
The Polish pharmaceutical and dietary supplement ecosystem is undergoing a dramatic structural transformation. As Central Europe's largest wellness and OTC remedy consumer market, Poland has emerged as a high-growth hub for scientifically backed botanical formulations, clean-label nutraceuticals, and preventive phytotherapy. Driven by an increasingly health-conscious populace in metropolitan centers such as Warsaw, Kraków, Wrocław, and Gdańsk, demand has shifted away from synthetic single-vitamin tablets toward complex botanical extracts with verifiable active marker concentrations.
To succeed in Poland’s rigorous regulatory environment—governed strictly by the Chief Sanitary Inspectorate (Główny Inspektorat Sanitarny - GIS) and harmonized with European Food Safety Authority (EFSA) guidance—brand owners and pharmaceutical distributors require more than simple toll manufacturing. They demand a vertically integrated Phytopharma Formulations Manufacturer & Factory that combines pharmaceutical-grade analytical testing, low-temperature extraction technology, and robust regulatory dossier support.
Polish notifications require complete safety data, heavy metal assay bounds (Lead, Cadmium, Mercury), pesticide residue screening per Ph. Eur. 2.8.13, and zero ethylene oxide (EtO) contamination verification.
Integration of novel delivery technologies—including liposomal liquid carriers, cyclodextrin complexation, and enteric-coated botanical micro-pellets—maximizing plasma concentration of active phytochemicals.
From concept feasibility screening, pilot batch stability testing (ICH guidelines Zone II/IVa), to custom artwork, primary blister/bottle filling, and direct sea/air freight to Gdynia or Warsaw logistics terminals.
Polish consumers exhibit distinct preferences across healthcare distribution channels, including apteka (pharmacies), specialized green stores (sklepy zielarsko-medyczne), and rapidly growing e-commerce platforms. To cater to these multi-channel demands, our manufacturing facility operates 5 specialized dosage production blocks:
| Dosage Platform | Annual Factory Output | Key Technical Features | Polish Market Application Focus |
|---|---|---|---|
| Solid Oral Tablets & Caplets | 400 Million Units | Direct compression, modified/sustained release, film & enteric coating, moisture-barrier wrapping. | Cardiovascular herbal blends, Liver support (Silymarin/Phospholipids), Joint care. |
| Hard Shell & Soft Gel Capsules | 140 Million Units | Vegetarian HPMC & gelatin shells, low-humidity probiotic/botanical encapsulation, band-sealed liquids. | Adaptogens (Ashwagandha, Rhodiola), Nootropics, Omega-3 + Phytosterol suspensions. |
| Nutritional Diskettes & Chewables | 100 Million Units | High-protein matrices, precise active dosing, crunch technology, pleasant mouthfeel without chalkiness. | Pediatric growth formulas, Geriatric dysphagia nutrition, Medical clinical foods. |
| Oral Liquids, Syrups & Drops | 70 Million Units | Preservative-free aseptic liquid lines, amber glass/PET filling, calibrated dropper cap integration. | Cough & upper respiratory phytotherapy, Immunomodulatory syrups, Bio-fermented liquids. |
| Functional Granules & Powders | 35,000 Metric Tons | Fluid-bed granulation, high-shear blending, instantized botanical sachet filling, vacuum drum packaging. | Sports protein blends, Electrolyte recovery sachets, Collagen & botanical anti-aging powders. |
With over 38 years of specialized formulation experience and an extensive portfolio of 850+ commercialized SKUs worldwide, our infrastructure is engineered to lower capital expenditure and reduce time-to-market for European partners. Located within advanced cGMP production campuses, our technical infrastructure bridges the gap between raw botanical agriculture and finished clinical-grade pharmaceuticals.
Every batch dispatched to Poland undergoes comprehensive analytical testing inside our ISO/IEC 17025 accredited laboratories. Utilizing High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS), we guarantee:
Navigating Polish food supplement notifications via the GIS electronic portal can be complex. Our dedicated regulatory affairs department provides complete document packages including:
Whether you require initial pilot batches (10,000–50,000 units) to test consumer response in Poland or full-scale commercial container loads, our flexible pilot plants mirror production-scale equipment, preventing formulation rework during scaling.
Connect directly with our senior formulation scientists and export specialists. Request our detailed product master catalog, request custom feasibility reviews, or schedule a virtual audit of our manufacturing facility.
